Literature DB >> 8814991

The CD44 proteins in embryonic development and in cancer.

L Sherman1, J Sleeman, P Dall, A Hekele, J Moll, H Ponta, P Herrlich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8814991     DOI： 10.1007/978-3-642-61107-0_15

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  18 in total

1.  CD44 variant exons in leukemia and lymphoma.

Authors:  Elif Akisik; Sevil Bavbek; Nejat Dalay
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

Review 2.  "...those left behind." Biology and oncology of invasive glioma cells.

Authors:  M E Berens; A Giese
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

3.  Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator.

Authors:  H König; H Ponta; P Herrlich
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

Review 4.  Stem cell stages and the origins of colon cancer: a multidisciplinary perspective.

Authors:  Elena V Gostjeva; William G Thilly
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

5.  Structural basis for homodimerization of the Src-associated during mitosis, 68-kDa protein (Sam68) Qua1 domain.

Authors:  N Helge Meyer; Konstantinos Tripsianes; Michelle Vincendeau; Tobias Madl; Fatiha Kateb; Ruth Brack-Werner; Michael Sattler
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

6.  Trans-acting factors regulate the expression of CD44 splice variants.

Authors:  H Konig; J Moll; H Ponta; P Herrlich
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

7.  CD44 isoform expression in the diffuse neuroendocrine system. II. Benign and malignant tumors.

Authors:  P Komminoth; W K Seelentag; P Saremaslani; P U Heitz; J Roth
Journal:  Histochem Cell Biol       Date:  1996-12       Impact factor: 4.304

8.  Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion.

Authors:  Chonghui Cheng; Phillip A Sharp
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

9.  Lipid raft association restricts CD44-ezrin interaction and promotion of breast cancer cell migration.

Authors:  Simona Donatello; Irina S Babina; Lee D Hazelwood; Arnold D K Hill; Ivan R Nabi; Ann M Hopkins
Journal:  Am J Pathol       Date:  2012-09-29       Impact factor: 4.307

Review 10.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.